845751-70-4

Basic information

• Product Name: 7-Bromo-2-methyl-2H-indazole-3-carbaldehyde
• Synonyms: 7-Bromo-2-methyl-2H-indazole-3-carbaldehyde;7-Bromo-2-methyl-2H-indazole-3-carboxaldehyde
• CAS NO: 845751-70-4
• Molecular Formula: C₉H₇BrN₂O
• Molecular Weight: 239.071
• Mol File: 845751-70-4.mol

Chemical Properties

• Boiling Point: 397.845 °C at 760 mmHg
• Flash Point: 194.41 °C
• Appearance: /
• Density: 1.65 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.671
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 7-Bromo-2-methyl-2H-indazole-3-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Bromo-2-methyl-2H-indazole-3-carbaldehyde(845751-70-4)
• EPA Substance Registry System: 7-Bromo-2-methyl-2H-indazole-3-carbaldehyde(845751-70-4)

Safety Data

• Hazardous Substances Data: 845751-70-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
7-Bromo-2-methyl-2H-indazole-3-carbaldehyde is utilized as a key intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs due to its potent biological activities.
Used in Agrochemical Synthesis:
7-Bromo-2-methyl-2H-indazole-3-carbaldehyde is also employed in the synthesis of agrochemicals, where its properties are leveraged to create substances that can protect crops and enhance agricultural productivity.
Used in Organic Synthesis:
7-Bromo-2-methyl-2H-indazole-3-carbaldehyde is used as a reagent in organic synthesis, enabling the preparation of various indazole derivatives that are of interest in medicinal chemistry.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 7-Bromo-2-methyl-2H-indazole-3-carbaldehyde is used for the preparation of indazole derivatives that exhibit diverse pharmacological properties, making them valuable for the development of therapeutic agents.
Used in Drug Development:
As a chemical building block, 7-Bromo-2-methyl-2H-indazole-3-carbaldehyde is instrumental in the development of new drugs, with its potential therapeutic applications being a subject of extensive study.

InChI:InChI=1/C9H7BrN2O/c1-12-8(5-13)6-3-2-4-7(10)9(6)11-12/h2-5H,1H3

Upstream product

• 701910-14-7 7-bromo-2-methyl-2H-indazole 
• 68-12-2 N,N-dimethyl-formamide 
• 53857-58-2 7-bromo-1H-indazole 

Downstream Products

• 845751-83-9 C₁₅H₁₁BrCl₂N₂ 
• 845750-74-5 7-(2,4-Dichloro-phenyl)-2-methyl-2H-indazole-3-carbonitrile 
• 845750-73-4 [7-(2,4-Dichloro-phenyl)-2-methyl-2H-indazol-3-yl]-acetonitrile 
• 845751-55-5 [7-(2,4-dichloro-phenyl)-2-methyl-2H-indazol-3-yl]-methanol 
• 845751-85-1 N-[7-(2,4-dichloro-phenyl)-2-methyl-2H-indazol-3-ylmethyl]-N-methyl-acetamide 
• 845751-90-8 C₂₀H₂₀Cl₂N₄O₂ 
• 845751-86-2 7-(2,4-dichlorophenyl)-2-methyl-2H-indazole-3-carbaldehyde 

Relevant articles and documents

Heterocyclic GABAA subtype selective receptor modulators

The present invention provides a compound of the formula: or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Y, Ar, R1 and R2 are defined herein. Also provided are pharmaceutical compositions, methods of usin

GABANERGIC MODULATORS

This invention relates to the use of compounds of benzoindazole derivatives salts and solvates thereof for the preparation of a medicament for modulating alpha2 subtype GABA A receptors. The invention further relates to novel heterocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the use of compounds of formula (I) salts and solvates thereof for the preparation of a medicament for the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain.